To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. (HR-6867) · Congress.wiki
House Votes
Pending Committee
December 18, 2025 (1 week ago)
Referred to the House Committee on Energy and Commerce.
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
